()
has been a registered insider since 2003.
As Chief Executive Officer at CRISPR Therapeutics, last made a transaction on 5/30/2023.
InsiderInsights.com Purchase Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Purchases
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 6 |
50% |
17% |
-9% |
178 |
1 Year |
6 |
0% |
-- |
-- |
-- |
| 6 |
50% |
18% |
6% |
150 |
9 Month |
6 |
0% |
-- |
-- |
-- |
| 7 |
71% |
26% |
1% |
240 |
6 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
29% |
-1% |
-22% |
151 |
3 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
29% |
5% |
-7% |
113 |
1 Month |
7 |
0% |
-- |
-- |
-- |
| 7 |
57% |
-1% |
1% |
36 |
1 Week |
7 |
0% |
-- |
-- |
-- |
InsiderInsights.com Sales Scorecard
|
|
|
Transaction Date
|
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
Time From
Sales
|
Nq |
Hit
Rate
|
Mean
Return
|
Median
Return
|
Range of
Returns
|
| 14 |
36% |
56% |
58% |
285 |
1 Year |
14 |
0% |
-- |
-- |
-- |
| 17 |
53% |
36% |
-2% |
321 |
9 Month |
17 |
0% |
-- |
-- |
-- |
| 20 |
50% |
10% |
1% |
189 |
6 Month |
20 |
0% |
-- |
-- |
-- |
| 23 |
57% |
-0% |
-3% |
82 |
3 Month |
23 |
0% |
-- |
-- |
-- |
| 25 |
56% |
1% |
-4% |
57 |
1 Month |
25 |
0% |
-- |
-- |
-- |
| 26 |
58% |
-1% |
-1% |
34 |
1 Week |
26 |
0% |
-- |
-- |
-- |
| Scorecards Updated 6/14/2023 11:37 AM EST |
Latest Transaction Date: |
5/30/2023 |
| Average days between Transaction and Entered Dates: |
3 |
